Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 5
1988 2
1989 1
1990 3
1991 3
1994 1
1997 2
1998 6
1999 1
2000 2
2001 2
2002 7
2003 4
2004 4
2005 4
2006 6
2007 4
2008 8
2009 4
2010 10
2011 8
2012 4
2013 2
2014 6
2015 6
2016 5
2017 5
2018 4
2019 10
2020 6
2021 2
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Non-invasive diagnosis of liver fibrosis and cirrhosis.
Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Lurie Y, et al. World J Gastroenterol. 2015 Nov 7;21(41):11567-83. doi: 10.3748/wjg.v21.i41.11567. World J Gastroenterol. 2015. PMID: 26556987 Free PMC article. Review.
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
Acute Kidney Injury and Hair-Straightening Products: A Case Series.
Bnaya A, Abu-Amer N, Beckerman P, Volkov A, Cohen-Hagai K, Greenberg M, Ben-Chetrit S, Ben Tikva Kagan K, Goldman S, Navarro HA, Sneineh MA, Rozen-Zvi B, Borovitz Y, Tobar A, Yanay NB, Biton R, Angel-Korman A, Rappoport V, Leiba A, Bathish Y, Farber E, Kaidar-Ronat M, Schreiber L, Shashar M, Kazarski R, Chernin G, Itzkowitz E, Atrash J, Iaina NL, Efrati S, Nizri E, Lurie Y, Ben Itzhak O, Assady S, Kenig-Kozlovsky Y, Shavit L. Bnaya A, et al. Among authors: lurie y. Am J Kidney Dis. 2023 Jul;82(1):43-52.e1. doi: 10.1053/j.ajkd.2022.11.016. Epub 2023 Jan 5. Am J Kidney Dis. 2023. PMID: 36610611
The Toxicology Investigators Consortium 2022 Annual Report.
Amaducci AM, Campleman SL, Li S, Karshenas DL, Spyres MB, Farrugia LA, Kang AM, Culbreth RE, Wax PM, Brent J, Aldy K; Toxicology Investigators Consortium Study Group. Amaducci AM, et al. J Med Toxicol. 2023 Oct;19(4):313-340. doi: 10.1007/s13181-023-00962-2. Epub 2023 Aug 29. J Med Toxicol. 2023. PMID: 37644342
Celiac disease.
Malnick SD, Lurie Y, Beergabel M, Bass DD. Malnick SD, et al. Among authors: lurie y. Postgrad Med. 1997 Jun;101(6):239-44. doi: 10.3810/pgm.1997.06.233. Postgrad Med. 1997. PMID: 9194877 Review.
Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trial.
Etzion O, Hamid S, Lurie Y, Gane EJ, Yardeni D, Duehren S, Bader N, Nevo-Shor A, Channa SM, Cotler SJ, Mawani M, Parkash O, Dahari H, Choong I, Glenn JS. Etzion O, et al. Among authors: lurie y. Hepatology. 2023 Jun 1;77(6):2093-2103. doi: 10.1097/HEP.0000000000000309. Epub 2023 Feb 20. Hepatology. 2023. PMID: 36800850 Free PMC article. Clinical Trial.
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy.
Yurdaydin C, Abbas Z, Buti M, Cornberg M, Esteban R, Etzion O, Gane EJ, Gish RG, Glenn JS, Hamid S, Heller T, Koh C, Lampertico P, Lurie Y, Manns M, Parana R, Rizzetto M, Urban S, Wedemeyer H; Hepatitis Delta International Network (HDIN). Yurdaydin C, et al. Among authors: lurie y. J Hepatol. 2019 May;70(5):1008-1015. doi: 10.1016/j.jhep.2018.12.022. Epub 2018 Dec 27. J Hepatol. 2019. PMID: 30982526 Review.
Septic arthritis.
Malnick SD, Beergabel M, Lurie Y. Malnick SD, et al. Among authors: lurie y. Lancet. 1998 Apr 4;351(9108):1060. doi: 10.1016/S0140-6736(05)79028-0. Lancet. 1998. PMID: 9546535 No abstract available.
138 results